Sepsis Clinical Trial
— APCIOfficial title:
After Pediatric Critical Illness (APCI)
More than 10,000 children are hospitalized in an PICU every year in Canada. While most of them will survive their PICU hospitalization and their critical illness, some children will not recover to their pre-illness level. Some may develop behavioral, physical, emotional or developmental problems and difficulties at school. All these problems are elements that are part of the Pediatric Post-Intensive Care Syndrome (PICS-p). It is important to understand the elements (risk factors) that play a role in the development of PICS-p. In Canada, there is no systematic follow-up for children after they leave the PICU. Understanding what can cause PICS-p (risk factors) and how much PICS-p has an impact on children and their family is very important to the family well-being.
Status | Not yet recruiting |
Enrollment | 690 |
Est. completion date | March 2029 |
Est. primary completion date | March 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 18 Years |
Eligibility | Inclusion Criteria: - Children =18yo hospitalized in PICU for =96 hours Exclusion Criteria: 1. gestational age <37 weeks or age >18 years at PICU entry; 2. admitted for congenital heart surgery (followed in neuro-cardiac clinics in most centers); 3. anticipated life expectancy <1year (e.g., active do not resuscitate status). |
Country | Name | City | State |
---|---|---|---|
Canada | Alberta Children's Hospital | Calgary | Alberta |
Canada | McMaster Children's Hospital | Hamilton | Ontario |
Canada | CHU Sainte-Justine | Montréal | Quebec |
Canada | Montreal Children Hospital | Montréal | Quebec |
Canada | Childrens Hospital of Eastern Ontario | Ottawa | Ontario |
Canada | Centre Hospitalier Universitaire de Sherbrooke | Sherbrooke | Quebec |
Canada | The Hospital for Sick Children | Toronto | Ontario |
Canada | BC Children Hospital | Vancouver | British Colombia |
Lead Sponsor | Collaborator |
---|---|
St. Justine's Hospital | Canadian Institutes of Health Research (CIHR) |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Describe families' healthcare requirements throughout their recovery process after PICU. | Descrie the variety of healthcare professional and medical required post PICU hospitalization. | Until 36 months post PICU discharge | |
Primary | Identify risk factors of PICS-p at 2 months post-PICU | Identification of modifiable and non-modifiable risk factors | 2 months after PICU discharge | |
Primary | Develop and validate a model predictive of PICS-p 2 months post PICU | The model will allow detection at PICU discharge of children in need of post-PICU follow-up | 2 months after PICU discharge | |
Secondary | Describe the incidence of each of the five domains of PICS-p across the first two years post-PICU | Identify which domain gets impacted and when during the course of the follow-up | At 2 months, 12, 18 months and 36 months post PICU discharge | |
Secondary | Uncover additional post-PICU morbidities not detected within the framework of PICS-p. | Detection of morbidities through the medical provider interview that are not included in the current framework. | Until 36 months post PICU discharge |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |